A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/496 (2006.01) A61K 47/40 (2006.01) A61K 47/48 (2006.01) A61K 47/12 (2006.01)
Patent
CA 2495864
An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a b-cyclodextrin, preferably, sulfobutyl ether b-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided.
L'invention concerne une formulation d'aripiprazole qui comprend l'agent antipsychotique aripiprazole sous la forme d'un complexe d'inclusion dans une bêta-cyclodextrine, de préférence, de la sulfobutyle éther bêta-cyclodextrine (SBECD), qui, sous la forme d'une substance injectable produit une irritation réversible, généralement de minime à bénigne, au niveau du site d'injection intramusculaire. L'invention concerne également une méthode permettant de minimiser ou de réduire l'irritation causée par l'aripiprazole au niveau d'un site d'injection intramusculaire et une méthode permettant de traiter la schizophrénie au moyen de la formulation.
Dominick Mark
Naringrekar Vijay
Nerurkar Manoj
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Aripiprazole complex formulation and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aripiprazole complex formulation and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aripiprazole complex formulation and method will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1633138